Evolus, Inc. (EOLS) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, everyone, and thank you for standing by. Welcome to Evelus's fourth quarter and full year 2025 earnings conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. As a reminder, today's conference call is being recorded in webcast live. All participants are in a listen-only mode, and after the speaker's remarks, there will be a question and answer session. I'd like to turn the conference call over to Narek Zagarian, Vice President and Head of Global Investor Relations and Corporate Communications. Please go ahead. Thank you, Operator, and welcome to everyone joining us on today's call to review Evelus' fourth quarter and full year 2025 financial results. Our fourth quarter and full year 2025 press release is now on our website at evelus.com. With me today are David Modazzetti, President and Chief Executive Officer, and Tatiana Mitchell, Chief Financial Officer. Rui Avalar, Chief Medical Officer and Head of R&D is also with us for the Q&A portion of the call. Today's call will include forward-looking statements. Actual results may differ materially due to risks and uncertainties outlined in our earnings press release and SEC filings. These forward-looking statements are based on current assumptions and we undertake no obligation to update them. Additionally, we will discuss certain non-GAAP financial measures. These measures should be considered in addition to and not as a substitute for our GAAP results. A reconciliation of GAAP to non-GAAP measures is included in today's earnings release. As a reminder, our earnings release and SEC filings are available on the SEC's website and on our investor relations website. Following the conclusion of today's call, a replay will b...